The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer
- PMID: 10546501
The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer
Abstract
Background: The prognostic factors in rectal adenocarcinoma are influenced by the tumor stage. However, it is important to evaluate the role of the surgeon as part of the prognostic factors affecting local recurrence and survival rates in a group of patients with mid-rectal cancer treated with low anterior resection at a cancer referral center, and those treated at general hospitals.
Materials and methods: Eighty-two patients with mid rectal adenocarcinoma stage II and III who underwent low anterior resection from January 1980 to December 1995, were retrospectively analyzed. Forty-two patients were treated at a cancer center (Group I) and 40 patients were treated at general hospitals (Group II). Cox regression analysis for local recurrence and survival was performed.
Results: There were 42 males and 40 females with a mean age of 55.8 +/- 14.9 years. No differences were found between both groups in terms of the following: age; gender; stage; grade of differentiation; number of positive lymph nodes; infiltration of neighboring organs, and administration of adjuvant chemoradiation therapy (POST RT). However, significant differences in the number of studied lymph nodes per specimen and follow-up were found. The median follow-up for the entire group was 49 months. Local recurrence occurred in 9.5% of patients in Group I vs. 50% in Group II (p = 0.0001). The 5-year survival in Group I was 63% vs. 54% in Group II (p = 0.04). The favorable prognostic factors for local recurrence and survival were: surgical treatment at a cancer center, and no lymph node metastases.
Conclusion: The prognostic factors for local recurrence and survival depends mainly on the surgeon and on the post-surgical tumor stage.
Similar articles
-
Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.Rev Invest Clin. 2001 Sep-Oct;53(5):388-95. Rev Invest Clin. 2001. PMID: 11795103 Review.
-
[Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].Ai Zheng. 2006 May;25(5):587-90. Ai Zheng. 2006. PMID: 16687079 Chinese.
-
Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.Dis Colon Rectum. 2004 Dec;47(12):2025-31. doi: 10.1007/s10350-004-0713-x. Dis Colon Rectum. 2004. PMID: 15657650
-
Results of long-term follow-up for transanal excision for rectal cancer.Am Surg. 2003 Aug;69(8):675-8; discussion 678. Am Surg. 2003. PMID: 12953825
-
Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.Am Surg. 2000 Apr;66(4):387-93. Am Surg. 2000. PMID: 10776877 Review.
Cited by
-
[Locally recurrent rectal carcinoma].Chirurg. 2004 Jan;75(1):38-44. doi: 10.1007/s00104-003-0795-3. Chirurg. 2004. PMID: 14740126 German.
-
Workload and surgeon's specialty for outcome after colorectal cancer surgery.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD005391. doi: 10.1002/14651858.CD005391.pub3. Cochrane Database Syst Rev. 2012. PMID: 22419309 Free PMC article.
-
Laparoscopy for rectal cancer: the need for randomized trials.Clin Colon Rectal Surg. 2006 Feb;19(1):13-8. doi: 10.1055/s-2006-939526. Clin Colon Rectal Surg. 2006. PMID: 20011448 Free PMC article.
-
Case report: Locoregional (perineum and inguinal) recurrence after treatment of rectal cancer by low anterior resection.World J Surg Oncol. 2013 Aug 12;11:186. doi: 10.1186/1477-7819-11-186. World J Surg Oncol. 2013. PMID: 23938088 Free PMC article.